Bioengineer, PhD, Michel Baijot is a life science executive bringing over 25 years of experience in building biologicals businesses with significant contribution in strategy, licensing, M&A and technology transfer.
His positions with biotech and big pharmaceutical companies as well as his tangible achievements reflect an in-depth knowledge of the business environment in both developed and emerging markets.
He is currently Board Director of IRE-Elit, the RadioPharma Division of IRE, and Board Director of OncoRadiomics. His previous positions include Executive Director Europe at Serum Institute of India, Head of Cipla Global Vaccine, Chief Business Officer at Janssen/Crucell, Vice President Worldwide Strategic Alliances and Business Development at GlaxoSmithKline Biologicals and Vice President Business Development at Innogenetics. He was Chairman of the Belgian Biotech Association during 5 years.